SK287956B6 - Composition comprising enzymes and use this enzymes - Google Patents

Composition comprising enzymes and use this enzymes Download PDF

Info

Publication number
SK287956B6
SK287956B6 SK826-2002A SK8262002A SK287956B6 SK 287956 B6 SK287956 B6 SK 287956B6 SK 8262002 A SK8262002 A SK 8262002A SK 287956 B6 SK287956 B6 SK 287956B6
Authority
SK
Slovakia
Prior art keywords
enzyme
composition
infection
plc
feed
Prior art date
Application number
SK826-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK8262002A3 (en
Inventor
David M. Anderson
Lin Liu
Humg-Yu Hsiao
Douglas W. Fodge
Original Assignee
Chemgen Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK287956(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corporation filed Critical Chemgen Corporation
Publication of SK8262002A3 publication Critical patent/SK8262002A3/sk
Publication of SK287956B6 publication Critical patent/SK287956B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SK826-2002A 1999-12-10 2000-12-08 Composition comprising enzymes and use this enzymes SK287956B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10
PCT/US2000/033466 WO2001041785A2 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection

Publications (2)

Publication Number Publication Date
SK8262002A3 SK8262002A3 (en) 2002-12-03
SK287956B6 true SK287956B6 (sk) 2012-07-03

Family

ID=22617824

Family Applications (1)

Application Number Title Priority Date Filing Date
SK826-2002A SK287956B6 (sk) 1999-12-10 2000-12-08 Composition comprising enzymes and use this enzymes

Country Status (31)

Country Link
US (2) US6780628B2 (es)
EP (1) EP1239872B1 (es)
JP (1) JP4871473B2 (es)
KR (1) KR100639746B1 (es)
CN (3) CN102172262B (es)
AR (2) AR026764A1 (es)
AT (1) ATE481981T1 (es)
AU (1) AU782831B2 (es)
BR (1) BRPI0016231B8 (es)
CA (1) CA2394856C (es)
CL (1) CL2008000057A1 (es)
CO (1) CO5280226A1 (es)
CR (1) CR6674A (es)
CZ (1) CZ304925B6 (es)
DE (1) DE60045010D1 (es)
DK (1) DK1239872T3 (es)
ES (1) ES2353371T3 (es)
HU (1) HU230301B1 (es)
IL (2) IL150048A0 (es)
IN (1) IN247731B (es)
MX (1) MX264033B (es)
MY (1) MY124714A (es)
NZ (1) NZ519404A (es)
PH (1) PH12000003381B1 (es)
PL (1) PL203054B1 (es)
PT (1) PT1239872E (es)
RU (1) RU2272419C2 (es)
SK (1) SK287956B6 (es)
TW (1) TWI255189B (es)
UA (1) UA78486C2 (es)
WO (1) WO2001041785A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
AU2005332655A1 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
NZ569186A (en) * 2005-12-15 2011-09-30 Chemgen Corp Enzymes for reduced immunological stress
PL2095825T3 (pl) 2006-11-28 2011-12-30 Cls Therapeutics Ltd Sposób leczenia ludzkich chorób związanych ze zwiększoną zawartością kwasu deoksyrybonukleinowego w przestrzeniach pozakomórkowych i tkankach i preparat leczniczy do przeprowadzenia tego sposobu
JP5901115B2 (ja) * 2007-06-08 2016-04-06 オーストラリアン ポールトリー シーアールシー ピーティーワイ リミテッド クロストリジウム毒素ｎｅｔｂ
WO2009085743A1 (en) * 2007-12-20 2009-07-09 Danisco Us Inc., Genencor Division Enzymatic prevention and control of biofilm
PL2254591T3 (pl) 2008-02-08 2018-01-31 Prothera Inc Inhibicja i leczenie biofilmów żołądkowo-jelitowych
AU2013219820B2 (en) 2012-02-16 2015-02-26 Elanco Us Inc. Methods and compositions for reducing the environmental impact of animal waste
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
US11701410B2 (en) 2015-05-22 2023-07-18 Cls Therapeutics Limited Extracellular DNA as a therapeutic target in neurodegeneration
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
JP2021510539A (ja) 2018-01-16 2021-04-30 シーエルエス セラピューティクス リミテッドＣＬＳ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ デオキシリボヌクレアーゼ（ＤＮａｓｅ）活性を有する酵素の肝臓発現による疾患の処置
MX2020009045A (es) * 2018-03-02 2020-10-12 Evonik Operations Gmbh Procedimiento in vitro para detectar disfuncion de la barrera intestinal en animales mediante la determinacion de ovotransferrina.
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
DE229810T1 (de) 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
CA2084071C (en) 1990-05-29 2004-09-28 Douglas Walter Fodge Hemicellulase supplement to improve the energy efficiency of hemicellulose-containing food and animal feed
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
MY134684A (en) * 1995-05-15 2007-12-31 Gist Brocades Bv Application of phospholipases in animal feed
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
CN1092495C (zh) * 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
WO1998018912A1 (en) * 1996-10-31 1998-05-07 Novo Nordisk A/S Novel phospholipase, production and use thereof
PL347250A1 (en) * 1998-10-15 2002-03-25 Dsm Nv Antimicrobial enzymes in animal feed
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116028A1 (en) * 2001-02-20 2002-08-22 Wilson Greatbatch MRI-compatible pacemaker with pulse carrying photonic catheter providing VOO functionality

Also Published As

Publication number Publication date
WO2001041785A2 (en) 2001-06-14
PL356175A1 (en) 2004-06-14
WO2001041785A3 (en) 2002-01-24
ES2353371T3 (es) 2011-03-01
DK1239872T3 (da) 2010-10-25
JP2003520207A (ja) 2003-07-02
CN101327320A (zh) 2008-12-24
IL150048A (en) 2016-09-29
CO5280226A1 (es) 2003-05-30
TWI255189B (en) 2006-05-21
US20040223961A1 (en) 2004-11-11
UA78486C2 (uk) 2007-04-10
RU2272419C2 (ru) 2006-03-27
BRPI0016231B1 (pt) 2016-10-04
KR20020069204A (ko) 2002-08-29
KR100639746B1 (ko) 2006-10-30
PH12000003381B1 (en) 2010-04-16
CR6674A (es) 2007-02-22
NZ519404A (en) 2004-05-28
AU2577601A (en) 2001-06-18
PT1239872E (pt) 2010-12-03
AU782831B2 (en) 2005-09-01
ATE481981T1 (de) 2010-10-15
US6780628B2 (en) 2004-08-24
CN102172262A (zh) 2011-09-07
IN2002DE00585A (es) 2009-03-20
SK8262002A3 (en) 2002-12-03
CZ304925B6 (cs) 2015-01-28
MY124714A (en) 2006-06-30
AR089799A2 (es) 2014-09-17
DE60045010D1 (de) 2010-11-04
EP1239872B1 (en) 2010-09-22
EP1239872A2 (en) 2002-09-18
AR026764A1 (es) 2003-02-26
CA2394856C (en) 2011-05-10
CL2008000057A1 (es) 2008-03-14
US20020048576A1 (en) 2002-04-25
US7723091B2 (en) 2010-05-25
IL150048A0 (en) 2002-12-01
MX264033B (es) 2009-01-22
CN102172262B (zh) 2014-03-05
IN247731B (es) 2011-05-13
HUP0203402A3 (en) 2004-12-28
JP4871473B2 (ja) 2012-02-08
HUP0203402A2 (hu) 2003-02-28
CN1433319A (zh) 2003-07-30
HU230301B1 (hu) 2015-12-28
CZ20022007A3 (cs) 2002-11-13
PL203054B1 (pl) 2009-08-31
BR0016231A (pt) 2003-06-24
MXPA02005735A (es) 2003-10-14
BRPI0016231B8 (pt) 2021-05-25
CA2394856A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
RU2272419C2 (ru) Композиция для перорального введения птицам или животным для лечения или снижения риска инфекции пищеварительного тракта (варианты), ее применение (варианты) и способ лечения или снижения риска инфекции пищеварительного тракта (варианты)
US20110014178A1 (en) Antimicrobial Composition and Method for Use
KR100730604B1 (ko) 동물 사료용 첨가제
US20170156371A1 (en) Enzymes for reduced immunological stress
EP0681787B1 (en) Use of an enzyme for manufacturing an agent for the treatment and/or prophylaxis of coccidiosis

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: ELI LILLY AND COMPANY, INDIANAPOLIS, IN, US

Free format text: FORMER OWNER: CHEMGEN CORPORATION, GAITHERSBURG, MD, US

Effective date: 20120521

PC4A Assignment and transfer of rights

Owner name: ELANCO US INC., GREENFIELD, IN, US

Free format text: FORMER OWNER: ELI LILLY AND COMPANY, INDIANAPOLIS, IN, US

Effective date: 20180410

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20191208